Armata Pharmaceuticals, Inc.
ARMP
$1.91
-$0.10-4.98%
AMEX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -60.24% | -58.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -60.24% | -58.46% | |||
| Cost of Revenue | -83.90% | 10,342.11% | |||
| Gross Profit | 84.80% | -1,326.15% | |||
| SG&A Expenses | -2.11% | 2.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.26% | -7.50% | |||
| Operating Income | 22.28% | -8.03% | |||
| Income Before Tax | -351.19% | 147.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -351.19% | 147.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -351.19% | 147.44% | |||
| EBIT | 22.28% | -8.03% | |||
| EBITDA | 23.08% | -7.58% | |||
| EPS Basic | -351.04% | 147.46% | |||
| Normalized Basic EPS | 14.29% | -10.57% | |||
| EPS Diluted | 62.35% | -245.94% | |||
| Normalized Diluted EPS | 14.85% | 32.30% | |||
| Average Basic Shares Outstanding | 0.00% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.67% | 63.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||